发明名称 BENZYLATED PDE4 INHIBITORS
摘要 The present invention is directed to a method for reducing the emetogenic effects of PDE inhibitors, and more particularly is directed to compounds having PDE4 inhibition activity with little or no emetogenic side-effects, and chemical methods including benzylation for preparing such compounds. A benzyl group may be attached to either a carbon or nitrogen atom of a PDE4 inhibitor. Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, and then react the resulting nucleophilic PDE4 inhibitor with a benzylating agent, e.g. benzyl bromide or a derivative thereof.
申请公布号 WO0168600(A2) 申请公布日期 2001.09.20
申请号 WO2001CA00345 申请日期 2001.03.16
申请人 INFLAZYME PHARMACEUTICALS LIMITED;LAUENER, RONALD, W.;BURGOYNE, DAVID, L.;REBSTEIN, PATRICK, J.;MACKENZIE, LLOYD, F.;ZHOU, YUANLIN;SHEN, YAPING 发明人 LAUENER, RONALD, W.;BURGOYNE, DAVID, L.;REBSTEIN, PATRICK, J.;MACKENZIE, LLOYD, F.;ZHOU, YUANLIN;SHEN, YAPING
分类号 C07C255/46;C07C271/60;C07D207/26;C07D213/75;C07D233/32;C07D239/10;C07D473/04;C07D473/06;(IPC1-7):C07D207/00 主分类号 C07C255/46
代理机构 代理人
主权项
地址
您可能感兴趣的专利